Redo-TAVI with the SAPIEN 3 valve in degenerated calcified CoreValve/Evolut explants
医学
心脏病学
内科学
作者
David S. Meier,Anish Nigade,Althea Lai,Kyle Dorman,Hacina Gill,Shahnaz Javani,Mariama Akodad,David Wood,Toby Rogers,Rishi Puri,Keith B. Allen,Adnan K. Chhatriwalla,Michael J. Reardon,Gilbert H.L. Tang,Vinayak Bapat,John G. Webb,Shinichi Fukuhara,Stephanie Sellers
出处
期刊:Eurointervention [Europa Digital and Publishing] 日期:2024-11-01卷期号:20 (22): 1390-1404
Redo-transcatheter aortic valve implantation (TAVI) is the treatment of choice for failed transcatheter aortic valves. Currently, implantation of a SAPIEN 3 (S3) is indicated for redo-TAVI in degenerated CoreValve/Evolut (CV/EV) transcatheter aortic valves (TAVs) but is not well understood.